Pyroptosis and pyroptosis-inducing cancer drugs

Acta Pharmacol Sin. 2022 Oct;43(10):2462-2473. doi: 10.1038/s41401-022-00887-6. Epub 2022 Mar 14.

Abstract

Pyroptosis, an inflammatory form of lytic cell death, is a type of cell death mediated by the gasdermin (GSDM) protein family. Upon recognizing exogenous or endogenous signals, cells undergo inflammasome assembly, GSDM cleavage, the release of proinflammatory cytokines and other cellular contents, eventually leading to inflammatory cell death. In this review, we discuss the roles of the GSDM family for anti-cancer functions and various antitumor drugs that could activate the pyroptosis pathways.

Keywords: GSDMD; GSDME; apoptosis; caspase; inflammasome; pyroptosis.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents* / pharmacology
  • Antineoplastic Agents* / therapeutic use
  • Cytokines
  • Inflammasomes / metabolism
  • Neoplasm Proteins / metabolism
  • Neoplasms* / drug therapy
  • Pyroptosis* / drug effects

Substances

  • Antineoplastic Agents
  • Cytokines
  • Inflammasomes
  • Neoplasm Proteins